Secreted phosphoprotein 1 regulates natural compound 3',4',5,7-tetrahydroxyflavone to inhibit mast cell-mediated allergic inflammation
BACKGROUND: Mast cells (MCs) are important effector cells in anaphylaxis and anaphylactic disease. 3',4',5,7-tetrahydroxyflavone (THF) presents in many medicinal plants and exerts a variety of pharmacological effects. In this study, we evaluated the effect of THF on C48/80-induced anaphylaxis and the mechanisms underlying its effects, including the role of secreted phosphoprotein 1 (SPP1), which has not been reported to IgE-independent MC activation.
RESULTS: THF inhibited C48/80-induced Ca2+ flow and degranulation via the PLCγ/PKC/IP3 pathway in vitro. RNA-seq showed that THF inhibited the expression of SPP1 and downstream molecules. SPP1 is involved in pseudo-anaphylaxis reactions. Silencing SPP1 affects the phosphorylation of AKT and P38. THF suppressed C48/80-induced paw edema, hypothermia and serum histamine, and chemokines release in vivo.
CONCLUSIONS: Our results validated SPP1 is involved in IgE-independent MC activation anaphylactoid reactions. THF inhibited C48/80-mediated anaphylactoid reactions both in vivo and in vitro, suppressed calcium mobilization and inhibited SPP1-related pathways.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Immunopharmacology and immunotoxicology - 45(2023), 6 vom: 01. Dez., Seite 672-681 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hu, Shiling [VerfasserIn] |
---|
Links: |
---|
Themen: |
106441-73-0 |
---|
Anmerkungen: |
Date Completed 06.12.2023 Date Revised 06.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/08923973.2023.2228478 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358408687 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358408687 | ||
003 | DE-627 | ||
005 | 20231226074657.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/08923973.2023.2228478 |2 doi | |
028 | 5 | 2 | |a pubmed24n1194.xml |
035 | |a (DE-627)NLM358408687 | ||
035 | |a (NLM)37339357 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hu, Shiling |e verfasserin |4 aut | |
245 | 1 | 0 | |a Secreted phosphoprotein 1 regulates natural compound 3',4',5,7-tetrahydroxyflavone to inhibit mast cell-mediated allergic inflammation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2023 | ||
500 | |a Date Revised 06.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Mast cells (MCs) are important effector cells in anaphylaxis and anaphylactic disease. 3',4',5,7-tetrahydroxyflavone (THF) presents in many medicinal plants and exerts a variety of pharmacological effects. In this study, we evaluated the effect of THF on C48/80-induced anaphylaxis and the mechanisms underlying its effects, including the role of secreted phosphoprotein 1 (SPP1), which has not been reported to IgE-independent MC activation | ||
520 | |a RESULTS: THF inhibited C48/80-induced Ca2+ flow and degranulation via the PLCγ/PKC/IP3 pathway in vitro. RNA-seq showed that THF inhibited the expression of SPP1 and downstream molecules. SPP1 is involved in pseudo-anaphylaxis reactions. Silencing SPP1 affects the phosphorylation of AKT and P38. THF suppressed C48/80-induced paw edema, hypothermia and serum histamine, and chemokines release in vivo | ||
520 | |a CONCLUSIONS: Our results validated SPP1 is involved in IgE-independent MC activation anaphylactoid reactions. THF inhibited C48/80-mediated anaphylactoid reactions both in vivo and in vitro, suppressed calcium mobilization and inhibited SPP1-related pathways | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a 3’,4’,5,7-tetrahydroxyflavone | |
650 | 4 | |a IgE-independent MC activation | |
650 | 4 | |a SPP1 | |
650 | 4 | |a mast cell | |
650 | 4 | |a pseudo-anaphylaxis | |
650 | 7 | |a Luteolin |2 NLM | |
650 | 7 | |a KUX1ZNC9J2 |2 NLM | |
650 | 7 | |a Osteopontin |2 NLM | |
650 | 7 | |a 106441-73-0 |2 NLM | |
650 | 7 | |a Immunoglobulin E |2 NLM | |
650 | 7 | |a 37341-29-0 |2 NLM | |
700 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
700 | 1 | |a Bai, Haoyun |e verfasserin |4 aut | |
700 | 1 | |a Feng, Chaohua |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Zhenqi |e verfasserin |4 aut | |
700 | 1 | |a Xue, Zhuoyin |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Wen |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yongjing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Nan |e verfasserin |4 aut | |
700 | 1 | |a He, Langchong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunopharmacology and immunotoxicology |d 1996 |g 45(2023), 6 vom: 01. Dez., Seite 672-681 |w (DE-627)NLM012646636 |x 1532-2513 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2023 |g number:6 |g day:01 |g month:12 |g pages:672-681 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/08923973.2023.2228478 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2023 |e 6 |b 01 |c 12 |h 672-681 |